{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Agenus Inc."},"Symbol":{"label":"Symbol","value":"AGEN"},"Address":{"label":"Address","value":"3 FORBES ROAD, LEXINGTON, Massachusetts, 02421-7305, United States"},"Phone":{"label":"Phone","value":"+1 781 674-4400"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe &amp; Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.agenusbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Craig Winter","title":"Chief Information Officer"},{"name":"Garo H. Armen","title":"Chairman &amp; Chief Executive Officer"},{"name":"Steven OÃ†Day","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}